In a report released yesterday, Carter Gould from Barclays maintained a Hold rating on Pfizer (PFE – Research Report), with a price target of $52.00. The company's shares closed last Friday at $51.59. According to TipRanks.com, Gould is a 3-star analyst with an average return of 3.9% and a 49.5% success rate. Gould covers the Healthcare sector, focusing on stocks such as Molecular Templates, Merck & Company, and Eli Lilly & Co. Pfizer has an analyst consensus of Moderate Buy, with a price target consensus of $58.92. See the top stocks recommended by analysts >> The company has a one-year high of $61.71 and a one-year low of $38.82.
https://www.tipranks.com/news/blurbs/pfizer-pfe-gets-a-hold-rating-from-barclays-4?utm_source=advfn.com&utm_medium=referral
Pfizer (NYSE:PFE)
Historical Stock Chart
From Aug 2022 to Sep 2022 Click Here for more Pfizer Charts.
Pfizer (NYSE:PFE)
Historical Stock Chart
From Sep 2021 to Sep 2022 Click Here for more Pfizer Charts.